These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20564467)

  • 1. Blood replacement with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules.
    Chang TM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(4):418-30. PubMed ID: 20564467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temperature stability of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] in the form of a solution or in the lyophilized form during storage at -80 °C, 4 °C, 25 °C and 37 °C or pasteurization at 70 °C.
    Bian YZ; Guo C; Chang TM
    Artif Cells Nanomed Biotechnol; 2016; 44(1):41-7. PubMed ID: 26613265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of polyethylene-glycol-polylactide nano-dimension artificial red blood cells in maintaining systemic hemoglobin levels and prevention of methemoglobin formation.
    Chang TM; Powanda D; Yu WP
    Artif Cells Blood Substit Immobil Biotechnol; 2003 Aug; 31(3):231-47. PubMed ID: 12906306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanobiotechnology for hemoglobin-based blood substitutes.
    Chang TM
    Crit Care Clin; 2009 Apr; 25(2):373-82, Table of Contents. PubMed ID: 19341914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Nanodimension artificial red blood cells that act as O2 and CO2 carrier with enhanced antioxidant activity: PLA-PEG nanoencapsulated PolySFHb-superoxide dismutase-catalase-carbonic anhydrase.
    Gao W; Bian Y; Chang TM
    Artif Cells Nanomed Biotechnol; 2013 Aug; 41(4):232-9. PubMed ID: 23336597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Jun; 40(3):197-9. PubMed ID: 22409281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanobiotechnological modification of hemoglobin and enzymes from this laboratory.
    Chang TM
    Biochim Biophys Acta; 2008 Oct; 1784(10):1435-40. PubMed ID: 18565337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant.
    Bian Y; Rong Z; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2011 Jun; 39(3):127-36. PubMed ID: 21574914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin-based red blood cell substitutes.
    Chang TM
    Artif Organs; 2004 Sep; 28(9):789-94. PubMed ID: 15320941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant.
    Bian Y; Rong Z; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Feb; 40(1-2):28-37. PubMed ID: 21689051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lowering of elevated tissue PCO2 in a hemorrhagic shock rat model after reinfusion of a novel nanobiotechnological polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase that is an oxygen and a carbon dioxide carrier with enhanced antioxidant properties.
    Bian Y; Wei G; Chang TM
    Artif Cells Nanomed Biotechnol; 2013 Feb; 41(1):60-8. PubMed ID: 23347056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-linked polyhemoglobin-superoxide dismutase-catalase supplies oxygen without causing blood-brain barrier disruption or brain edema in a rat model of transient global brain ischemia-reperfusion.
    Powanda DD; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2002 Jan; 30(1):23-37. PubMed ID: 12000224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties.
    D'Agnillo F; Chang TM
    Nat Biotechnol; 1998 Jul; 16(7):667-71. PubMed ID: 9661202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified hemoglobin-based blood substitutes: crosslinked, recombinant and encapsulated hemoglobin.
    Chang TM
    Vox Sang; 1998; 74 Suppl 2():233-41. PubMed ID: 9704450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):551-66. PubMed ID: 17090428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future generations of red blood cell substitutes.
    Chang TM
    J Intern Med; 2003 May; 253(5):527-35. PubMed ID: 12702030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of hemoprotein-associated free radical events following oxidant challenge of crosslinked hemoglobin-superoxide dismutase catalase.
    D'Agnillo F; Chang TM
    Free Radic Biol Med; 1998 Apr; 24(6):906-12. PubMed ID: 9607600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two future generations of blood substitutes based on polyhemoglobin-SOD-catalase and nanoencapsulation.
    Chang TM; D'Agnillo F; Yu WP; Razack S
    Adv Drug Deliv Rev; 2000 Feb; 40(3):213-8. PubMed ID: 10837791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of polyhemoglobin-antioxidant enzyme complex on ischemia-reperfusion in kidney.
    Chang EJ; Lee TH; Mun KC; Kim HC; Suh SI; Bae JH; Kim SP; Cho KB; Hwang JS
    Transplant Proc; 2004 Sep; 36(7):1952-4. PubMed ID: 15518709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent and prominent examples of nano- and microarchitectures as hemoglobin-based oxygen carriers.
    Jansman MMT; Hosta-Rigau L
    Adv Colloid Interface Sci; 2018 Oct; 260():65-84. PubMed ID: 30177214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.